Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Peter J. Campbell, Moritz Gerstung et al.|Blood|2013Cited by 1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>Jyoti Nangalia, Elli Papaemmanuil, Anthony R. Green et al.|New England Journal of Medicine|2013Cited by 1.7k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring SideroblastsElli Papaemmanuil, Peter J. Campbell, Mario Cazzola et al.|New England Journal of Medicine|2011Cited by 1.2k
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaRaphaël Itzykson, Éric Solary, Claude Preudhomme et al.|Journal of Clinical Oncology|2013Cited by 543
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndromeAndrew Chase, Nicholas C.P. Cross|Haematologica|2012Cited by 71